Dr. Peter T. Gardner, MD
General Practice (General Practice Physician)
- Medicare participating
At a glance
- Medical school
- University of Tennessee, Hsc, College of Medicine (1993)
- Years since graduation
- 33
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 1,746
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1993Medical school: University of Tennessee, Hsc, College of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
General Practice Physician primary
TN license MD26391 -
Student in an Organized Health Care Education/Training Program
TN license 26391
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Jackson-Madison County General Hospital Jackson, TN
- West Tennessee Healthcare Milan Hospital Milan, TN
Medical groups
- Christian Family Medicine, LLC (32 clinicians)
- Physicians Quality Care PLLC (6 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,746
- Services billed
- 19,615
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Injection, dexamethasone sodium phosphate, 1 mg | 3,134 | 647 |
| Established patient office or other outpatient visit, 30-39 minutes | 1,920 | 950 |
| Established patient office or other outpatient visit, 20-29 minutes | 1,914 | 1,272 |
| Insertion of needle into vein for collection of blood sample | 1,597 | 866 |
| Injection, ceftriaxone sodium, per 250 mg | 994 | 219 |
| Injection, methylprednisolone acetate, 40 mg | 722 | 619 |
| Detection test by immunoassay with direct visual observation for influenza virus | 659 | 325 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 609 | 543 |
| Automated urinalysis test | 557 | 405 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 535 | 430 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Gabapentin Other prescribers in Jackson, TN | 25 |
| Azithromycin Other prescribers in Jackson, TN | 23 |
| Prednisone Other prescribers in Jackson, TN | 19 |
| Cyclobenzaprine Hcl Other prescribers in Jackson, TN | 16 |
| Doxycycline Hyclate Other prescribers in Jackson, TN | 15 |
| Cephalexin Other prescribers in Jackson, TN | 13 |
| Oxycodone-Acetaminophen (oxycodone hcl/acetaminophen) Other prescribers in Jackson, TN | 13 |
| Methylprednisolone Other prescribers in Jackson, TN | 12 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Jackson, TN | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $21.88 in total to this clinician.
| Amgen Inc. | $21.88 |
|---|
| Food and Beverage | $21.88 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 3 companies. The companies reported $584,661 in research payments for these studies, mostly to the institutions running them.
- A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age
ModernaTX, Inc. · Completed · NCT06602024 - A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults
Ipsen Innovation · Active, not recruiting · NCT06047457 - A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults
Ipsen Innovation · Active, not recruiting · NCT06047444 - A phase 3,global,randomized,modified double blind,placebo controlled,study to evaluate the efficacy,immunogenicity,and safety of IVX A12,a respiratory syncytial virus RSV and human metapneumovirus hMPV virus like part…
AstraZeneca Pharmaceuticals LP
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.